- CFO Spotlights
- Profiles
- Marc Panoff
Profile
Marc Panoff
Senior Vice President of Finance (Principal Financial and Accounting Officer), LB Pharmaceuticals Inc
A later filing names a successor. First published here October 28, 2026; built from records as of October 28, 2026.
Marc Panoff signed the annual report of LB Pharmaceuticals Inc on Form 10-K as Senior Vice President of Finance (Principal Financial and Accounting Officer), filed March 26, 2026.1 A later filing by LB Pharmaceuticals Inc, made on September 3, 2026, names Joseph M. Miller as its chief financial officer; the record holds no filing that reports the end of Marc Panoff's tenure.
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| LB Pharmaceuticals Inc (LBRX) Pharmaceutical Preparations | Senior Vice President of Finance (Principal Financial and Accounting Officer) | A later filing names a successor Joseph M. Miller, filed September 3, 2026 (filing) |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- March 26, 202610-K filed
Marc Panoff signed the annual report of LB Pharmaceuticals Inc on Form 10-K as Senior Vice President of Finance (Principal Financial and Accounting Officer), filed March 26, 2026.
/s/ Marc Panoff Senior Vice President of Finance (Principal Financial and Accounting Officer)
[1] Annual report on Form 10-K by LB Pharmaceuticals Inc, filed with the SEC on March 26, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Annual report on Form 10-K, LB Pharmaceuticals Inc. U.S. Securities and Exchange Commission, EDGAR, filed March 26, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or Marc Panoff wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.